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Molecular Characterization of Articular Cartilage from
Young Adults with Femoroacetabular Impingement
Shingo Hashimoto, MD, PhD, Muhammad Farooq Rai, PhD, Corey S. Gill, MD, Zhiqi Zhang, MD,
Linda J. Sandell, PhD, and John C. Clohisy, MD
Investigation performed at Washington University School of Medicine at Barnes-Jewish Hospital, St. Louis, Missouri

Background: Femoroacetabular impingement is a frequent cause of hip pain and may lead to secondary osteoarthritis,
yet little is known about the molecular events linking mechanical hip impingement and articular cartilage degeneration.
The first goal of this study was to quantify the expression of inflammatory cytokine and chemokine, matrix-degrading, and
extracellular matrix genes in articular cartilage harvested from control hips and hips with femoroacetabular impingement
and end-stage osteoarthritis. The second goal was to analyze the relative expression of these genes in articular cartilage
harvested at various stages of osteoarthritis.
Methods: Cartilage samples were obtained from thirty-two hips undergoing hip preservation surgery for femoroacetabular
impingement or hip arthroplasty. Three control cartilage samples were also analyzed. Specimens were graded intraoperatively
with regard to the severity of cartilage damage, the radiographic osteoarthritis grade was recorded, and quantitative RT-PCR
(real-time polymerase chain reaction) was performed to determine relative gene expression.
Results: Except for interleukin-1b (IL-1b) and CXCL2, the mRNA (messenger RNA) expression of all other chemokine
(IL-8, CXCL1, CXCL3, CXCL6, CCL3, and CCL3L1), matrix-degrading (matrix metalloproteinase [MMP]-13 and ADAMTS-4),
and structural matrix (COL2A1 [collagen, type II, alpha] and ACAN [aggregan]) genes was higher overall in cartilage from
hips with femoroacetabular impingement compared with hips with osteoarthritis and normal controls. The differences
reached significance (p £ 0.05) for seven of these ten quantified genes, with CXCL3, CXCL6, and COL2A1 being elevated
in the femoroacetabular impingement group compared with only the control group and IL-8, CCL3L1, ADAMTS-4, and
ACAN being elevated compared with both the osteoarthritis and control groups. When samples were grouped according to
the stage of the degenerative cascade, mRNA expression was relatively higher in one of the two middle stages of
femoroacetabular impingement (chondromalacia or cleavage/thinning), with the difference reaching significance for
IL-8, CXCL2, CXCL3, CCL3L1, and ACAN. ACAN expression was diminished in hips with osteoarthritis compared with
femoroacetabular impingement but elevated compared with the control articular cartilage.
Conclusions: Articular cartilage from the impingement zone of hips with femoroacetabular impingement (and particularly
those hips in the cleavage/thinning stage) expressed higher levels of certain inflammatory, anabolic, and catabolic genes,
representing a heightened metabolic state.
Clinical Relevance: The articular cartilage from the impingement zone of hips with femoroacetabular impingement was
metabolically hyperactive, supporting the concept that such impingement is a structural precursor to hip osteoarthritis.
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what is written in this work. The complete Disclosures of Potential
Conflicts of Interest submitted by authors are always provided with
the online version of the article.
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ecent advances in understanding structural hip disease
have bolstered the theory of secondary osteoarthritis1,2. In
this model of hip osteoarthritis pathophysiology, joint
degeneration is secondary to an abnormal mechanical environment commonly caused by femoroacetabular impingement. This
impingement results from a distinct morphologic abnormality
of the acetabular rim (pincer deformity) and/or the femoral headneck junction (cam deformity). These structural malformations
produce dynamic, repetitive abutment between the proximal aspect of the femur and the acetabular rim leading to labrochondral
dissociation, articular cartilage detachment, and progressive joint
degeneration3-5. In this model of secondary hip osteoarthritis,
underlying structural abnormalities of the acetabulum and proximal aspect of the femur causing femoroacetabular impingement
mediate progressive osteoarthritis and eventually hip joint failure1,4.
Despite increasing knowledge regarding femoroacetabular impingement and secondary osteoarthritis, this theory remains
controversial and the role of femoroacetabular impingement in the
pathophysiology of osteoarthritis continues to be questioned6.
Our understanding of the biology of osteoarthritis has
expanded markedly in recent years. Current information indicates
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that articular cartilage degeneration, characteristic of osteoarthritis, is mediated by several distinct molecular mediators
such as cytokines, chemokines, and metalloproteinases7 that
are released by intra-articular and periarticular soft tissues
(Table I). Cytokines are cell-signaling proteins produced by
chondrocytes and synovial cells within the hip joint that act
to stimulate inflammation and regulate extracellular matrix
homeostasis7. Interleukin-1b (IL-1b) is a cytokine that strongly
increases inflammation and is thought to play a pivotal role in
both early and late-stage osteoarthritis8. IL-1b causes articular
cartilage destruction in part by stimulating production of MMP
(matrix metalloproteinase)-13 and ADAMTS (a disintegrin
and metalloproteinase with thrombospondin motifs)-4, the
enzymes responsible for cleavage of the major structural proteins in the cartilage matrix (type-II collagen and aggrecan,
respectively)9-11. Additionally, more recent investigations have
implicated certain chemoattractive cytokines (chemokines) as
potential mediators of articular cartilage degeneration12-15. Chemokines represent a large family of structurally related inflammatory and immune system mediators that may have
important roles in normal articular cartilage physiology and

TABLE I Candidate Genes Important in the Potential Biological Link Between Femoroacetabular Impingement and Secondary Osteoarthritis
NCBI*
Accession No.

Gene Name

Symbol

Alias

Forward Primer

Reverse Primer

Metabolic
Role

NM_000576.2

Interleukin-1 beta

IL-1b

—

(59-TCCAGGAGAATGACCTGAGC-39)

(59-GTGATCGTACAGGTGCATCG-39)

Inflammation

NM_000584.3

Interleukin-8

IL-8

—

(59-GAAGGTGCAGTTTTGCCAAG-39)

(59-TGTGGTCCACTCTCAATCCTC-39)

Inflammation

NM_001511.2

Chemokine
(C-X-C) motif
ligand 1

CXCL1

GRO-a

(59-GGGAATTCACCCCAAGAAC-39)

(59-GATGCAGGATTGAGGCAAG-39)

Inflammation

NM_002089.3

Chemokine
(C-X-C) motif
ligand 2

CXCL2

GRO-b

(59-TGCAGGGAATTCACCTCAAG-39)

(59TCTTAACCATGGGCGATGC-39)

Inflammation

NM_002090.2

Chemokine
(C-X-C) motif
ligand 3

CXCL3

GRO-g

(59-ACCGAAGTCATAGCCACACTC-39)

(59-GGTGCTCCCCTTGTTCAGTA-39)

Inflammation

NM_002993.3

Chemokine
(C-X-C) motif
ligand 6

CXCL6

GCP-2

(59GTTTACGCGTTACGCTGAGAG-39)

(59-ACTTCCACCTTGGAGCACTG-39)

Inflammation

NM_002983.2

Chemokine
(C-C) motif
ligand 3

CCL3

MIP-1a

(59-GCAACCAGTTCTCTGCATCA-39)

(59-TGGCTGCTCGTCTCAAAGTA-39)

Inflammation

NM_021006.4

Chemokine
(C-C) motif
ligand 3-like 1

CCL3L1

LD78b

(59-GTCCTCTCTGCACCACTTGC-39)

(59-GGAAGATGACACTGGGCTTG-39)

Inflammation

NM_002427.3

Matrix
metalloproteinase 13

MMP-13

Collagenase 3

(59-TGGTCCAGGAGATGAAGACC-39)

(59-TCCTCGGAGACTGGTAATGG-39)

Degradation
(catabolism)

NM_005099.4

A disintegrin and
metalloproteinase
with thrombospondin
motifs 4

ADAMTS-4

—

(59-GGCTAAAGCGCTACCTGCTA-39)

(59-GAGTCACCACCAAGCTGACA-39)

Degradation
(catabolism)

NM_033150.2

Collagen, type II,
alpha

COL2A1

—

(59-CCCAGAGGTGACAAAGGAGA-39)

(59-CACCTTGGTCTCCAGAAGGA-39)

Synthesis
(anabolism)

NM_013227.3

Aggrecan

ACAN

—

(59-GGCACTAGTCAACCCTTTGG-39)

(59-CTGAACCCTGGTAACCCTGA-39)

Synthesis
(anabolism)

NM_002046.3

Glyceraldehyde3-phosphate
dehydrogenase

GAPDH

(59-ACCCAGAAGACTGTGGATGG-39)

(59-GAGGCAGGGATGATGTTCTG-39)

Housekeeping

G3PDH

*NCBI = National Center for Biotechnology Information.

Downloaded From: http://jbjs.org/ by a WASHINGTON UNIV SCHOOL OF MED User on 09/15/2013

1459
TH E JO U R NA L O F B O N E & JO I N T SU RG E RY J B J S . O RG
V O L U M E 9 5-A N U M B E R 16 A U G U S T 21, 2 013
d

d

d

M O L E C U L A R C H A R A C T E R I Z AT I O N
F R O M Y O U N G A D U LT S W I T H FAI

OF

ARTI CU LAR CARTILAGE

TABLE II Source of Cartilage Samples
Control

FAI*

OA*

3

25

7

Hips (no.)
Mean age (range) (yr)

28 (15 to 44)

24.1 (13 to 37)

52.7 (37 to 73)

Sex

3 female

17 male, 8 female

5 male, 2 female

Tissue source

Surgical specimen (DDH control†)

Surgical specimen

Surgical specimen

*FAI = femoroacetabular impingement, and OA = osteoarthritis. †DDH = developmental dysplasia of hip. The cartilage was harvested to prevent
26
secondary FAI after acetabular reorientation and was used as a control tissue as there were no signs of tissue degeneration at the time of surgery.

disease states16,17. Chemokine production is upregulated by
proinflammatory molecules such as IL-1b and tumor necrosis
factor alpha (TNF-a), and chemokines may play a role in osteoarthritis by recruiting inflammatory cells to injured cartilage, by directly stimulating inflammation and production of
degradative enzymes such as MMP-13, or by stimulating the
death of chondrocytes through apoptosis16,18,19.
Despite our improved understanding of hip pathomechanics
and osteoarthritis pathobiology, the cellular and molecular
‘‘links’’ between the pathologic mechanical environment and the
metabolic alterations of articular cartilage in hip osteoarthritis are
not understood. An improved understanding of these biologic
cascades will facilitate future disease staging and therapeutic strategies for pre-arthritic and early arthritic hip disease. Nevertheless,
characterization of the cellular and molecular events that mediate
articular cartilage degeneration remains problematic because of
the current limitations of animal models of hip osteoarthritis, the
questionable relevance of in vitro osteoarthritis models, and
the inherent limitations in obtaining and studying human cartilage
tissues from pre-arthritic and/or early arthritic hips.
Over the past decade, there has been an increased utilization of hip joint preservation procedures designed to surgically ‘‘normalize’’ or improve the mechanical environment of
pre-arthritic and early arthritic hips20,21. A common component
of hip joint preservation procedures for femoroacetabular impingement is resection of a prominent anterolateral femoral
head-neck junction to relieve mechanical impingement22-25.
The articular cartilage harvested from this tissue provides
unique biologic specimens for the analysis of metabolic activity
and gene expression in articular chondrocytes.
We quantified mRNA (messenger RNA) expression of
genes that are potentially important in the development of secondary osteoarthritis in hips with femoroacetabular impingement. The first goal of this study was to quantify the expression
of genes for inflammatory cytokines and chemokines (IL-1b,
IL-8, CXCL1, CXCL2, CXCL3, CXCL6, CCL3, and CCL3L1),
degradative enzymes (MMP-13 and ADAMTS-4), and major
structural proteins in the cartilage extracellular matrix (COL2A1
and ACAN) (see Table I for definitions) in articular cartilage
harvested from normal hips and hips with femoroacetabular
impingement and end-stage osteoarthritis. The second goal was
to analyze the relative expression of these genes in articular
cartilage harvested at various stages of the osteoarthritic cascade.

Materials and Methods
Patients and Cartilage Samples

W

e analyzed articular cartilage tissues from thirty-two patients (thirty-two
hips) undergoing hip preservation surgery for femoroacetabular impingement, total hip replacement, or hip resurfacing (Table II). All tissues were
obtained from the anterolateral femoral head-neck junction in the area of mechanical impingement. For comparison, articular cartilage samples without
signs of tissue degeneration (control samples) were obtained from patients
undergoing hip preservation surgery involving acetabular reorientation for developmental dysplasia of the hip. The anterolateral head-neck junction (which
was without signs of articular cartilage degeneration) was then removed from the
26
latter patients to prevent potential secondary femoroacetabular impingement .
The three patients (all female) from whom a control cartilage sample was obtained for comparison had a mean age of twenty-eight years (range, fifteen to
forty-four years). Each patient signed a research consent form for the study,
which was approved by the university’s institutional review board. All surgical
procedures were performed by a single surgeon (J.C.C.) from 2009 to 2011.
Twenty-five of the thirty-two non-control patients (and hips) were
treated with hip preservation surgery and formed the primary study group. All
of these hips were treated for symptomatic femoroacetabular impingement
with open femoral head-neck osteochondroplasty; arthroscopic procedures
performed during the study period to treat femoroacetabular impingement
were excluded because of the difficulties encountered in tissue harvesting and
processing. The mean age of these eight female and seventeen male patients was
24.1 years (range, thirteen to thirty-seven years). All patients had a clinical diagnosis of femoroacetabular impingement as determined by one of the authors
(J.C.C.). All had groin pain, restricted hip internal rotation in flexion, and a
positive anterior impingement test. All were evaluated with preoperative radio27
graphs made according to a previously published protocol and were found to
have structural abnormalities consistent with cam or combined cam and pincer
impingement. Additionally, the radiographic assessment of the osteoarthritis grade
28
according to the Tönnis classification system was recorded. Twelve (48%) of the
hips were Tönnis grade 0 (no radiographic evidence of osteoarthritis), nine (36%)
were grade 1 (sclerosis only), and four (16%) were grade 2 (moderate joint-space
narrowing). None were Tönnis grade 3 (advanced osteoarthritis with severe jointspace narrowing). All patients had undergone prior unsuccessful nonsurgical
treatment.
The remaining seven non-control patients were treated with primary
total hip replacement or hip resurfacing for end-stage osteoarthritis. The
mean age of these two female and five male patients was 52.7 years (range,
thirty-seven to seventy-three years). All had a diagnosis of osteoarthritis
with hip morphology consistent with femoroacetabular impingement and
Tönnis grade-3 osteoarthritis on radiographs. Specimens were obtained
from the anterolateral femoral head-neck junction of these hips in a fashion
identical to that in the hips with femoroacetabular impingement. These
served as a comparison group of biologic specimens representing end-stage
hip osteoarthritis.
At the time of surgery, the integrity of the articular cartilage at the
femoral head-neck junction was evaluated macroscopically and was classified
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Fig. 1

Normalized mRNA expression of selected cytokine and chemokine, matrix-degrading, and structural matrix genes (defined in Table I) in
articular cartilage samples obtained from hips with femoroacetabular impingement (FAI) and end-stage osteoarthritis (OA) compared with controls.
Except for IL-1b and CXCL2, the expression of all genes was higher in hips with FAI compared with controls and hips with OA. Significant differences
between two or more categories were observed for IL-8, CXCL3, CXCL6, CCL3L1, ADAMTS-4, COL2A1, and ACAN, indicating that the cartilage in
hips with FAI was metabolically more active than the cartilage in hips with OA and controls. The data are expressed as the mean and the standard
error of the mean relative to the mean expression of the control specimens. *P £ 0.05 compared with hips with FAI.¨P £ 0.05 between controls and
hips with OA.
3

with use of the system of Beck et al. . This system includes criteria to evaluate
the macroscopic appearance of the articular cartilage, integrity of the cartilage
surface, and fixation of the cartilage to the underlying subchondral bone (see
Appendix). This system was used by the senior surgeon (J.C.C.) to classify all
samples into one of five categories: normal, chondromalacia, debonding,
cleavage and/or thinning, or defect. The most severe area of disease in each
specimen was used for the final grading. After the cartilage was harvested from
the anterolateral impingement zone of the femoral head-neck junction, RNA
was extracted from the sample and quantitative RT-PCR (real-time polymerase
chain reaction) was performed to evaluate gene expression in the articular
cartilage. The genes selected for evaluation included genes for cytokines, chemokines, degradative enzymes, and extracellular matrix proteins thought to
play a role in osteoarthritis or joint degradation (Table I).

Isolation of RNA and Quantitative RT-PCR
The cartilage tissues were immersed promptly in TRIzol reagent (Invitrogen,
Carlsbad, California) on reception to avoid potential RNA degradation. In
addition, all RNA preparation was carried out under RNase-free conditions.

Isolation of total RNA and quantitative RT-PCR were carried out as
29,30
described previously, with slight modifications . Briefly, total RNA was first
extracted from the cartilage with TRIzol reagent according to the protocol
recommended by the manufacturer. After the RNA extraction, RNA clean-up
was performed with use of an RNeasy Mini Kit (Qiagen, Valencia, California).
Total RNA was reverse-transcribed with SuperScript II reverse transcriptase
(Invitrogen) to synthesize first-strand complementary DNA (cDNA). Using
this cDNA, quantitative RT-PCR was performed with 20 mL of reaction
mixture containing SYBR Green PCR Master Mix (Applied Biosystems, Foster
City, California) and primers on a 7500 Fast Real-Time PCR system (Applied
29,30
Biosystems). Primers
for quantitative RT-PCR were selected for each gene
(Table I), and the dissociation curve was determined. The primer design parameters included a primer size of 18 to 21 bp, a product size of 80 to 150 bp, a
primer annealing temperature of 59° to 61°C, and a primer GC content of 45% to
55%. Results were normalized to the glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) level. The three control articular cartilage samples and seven end-stage
osteoarthritis samples were analyzed for comparison. The comparative Ct
(threshold cycles) method was used to evaluate the expression level of each
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Fig. 2

Normalized mRNA expression of selected cytokine and chemokine, matrix-degrading, and structural matrix genes (defined in Table I) in articular cartilage
samples obtained from hips with femoroacetabular impingement (FAI) classified intraoperatively according to the Beck criteria (normal, chondromalacia,
cleavage/thinning, and defect) and hips with end-stage osteoarthritis (OA) compared with controls. The mRNA expression in the FAI cleavage/thinning
category was higher than those in the other FAI categories, OA, and normal control cartilage except in the cases of CXCL1, CXCL6, and MMP-13, for which the
expression in the FAI cleavage/thinning category remained relatively similar to that in the chondromalacia category. The mRNA expression levels of IL-8,
CXCL2, CXCL3, CCL3L1, and ACAN were significantly higher in the FAI cleavage/thinning category than in the other categories indicated by asterisks,
indicating that cartilage at the cleavage/thinning stage expressed more inflammatory and catabolic mediators. None of the other groups differed
significantly. The data are expressed as the mean and the standard error of the mean relative to the mean expression of the control specimens. A p value of
£0.05 was considered significant. *P £ 0.05. **P < 0.01. ***P < 0.001.
target gene relative to the level in the controls. All graphs depict the expression
level in each non-control patient group divided by that in the controls.

a Ruth L. Kirschstein National Research Service Award Fellowship (T32AR060719) from the NIH.

Statistical Analysis

Results
xpression of cytokine, chemokine, degradative enzyme,
and matrix genes was evaluated in three distinct groups of
articular cartilage specimens. The genes analyzed are shown in
Table I and the characteristics of the tissue sources are summarized in Table II. Gene expression in the twenty-five hips
with a clinical diagnosis of femoroacetabular impingement
was compared with gene expression in the three control
samples of cartilage from hips without osteoarthritis as well as the
seven samples obtained from hips with end-stage osteoarthritis

Data are expressed as the mean and the standard error of the mean unless
otherwise indicated. The nonparametric Mann-Whitney U test was used for
comparisons of normally distributed data among the groups. Analysis of variance (ANOVA) followed by the Tukey honestly significant difference post hoc
test were used for multiple comparisons. Differences in gene expression were
considered significant at a p value of £0.05.

Source of Funding
The study was funded by NIH (National Institutes of Health) grants R0136994,
R01AR050847, R02AR058978, and P30AR057235. M.F.R. is supported by

E
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at the time of total hip arthroplasty or hip resurfacing (Fig. 1).
Expression of all inflammatory cytokines and chemokines except
IL-1b and CXCL2 was elevated in the samples from the hips with
femoroacetabular impingement compared with the control
samples. The difference was significant (p £ 0.05) for IL-8,
CXCL3, CXCL6, and CCL3L1, and significant differences
were also observed for ADAMTS-4, COL2A1, and ACAN.
Expression of certain of these chemokine (IL-8 and CCL3L1),
matrix-degrading (ADAMTS-4), and extracellular matrix
(ACAN) genes was also higher in cartilage from hips with
femoroacetabular impingement compared with end-stage osteoarthritis. In addition, the gene expression differences between the control cartilage and the cartilage from hips with
end-stage osteoarthritis were variable and not significant except in the case of ACAN, which was significantly upregulated
in the osteoarthritis group.
Articular cartilage damage observed intraoperatively in
hips with femoroacetabular impingement and osteoarthritis
was graded in order to compare expression of cytokine, chemokine, degradative enzyme, and matrix genes in articular cartilage from different stages of the osteoarthritic cascade.
According to the Beck criteria, three (12%) of the hips with
femoroacetabular impingement were classified as showing a
normal appearance; thirteen (52%), chondromalacia; zero
(0%), debonding; five (20%), cleavage/thinning; and four
(16%), a full-thickness defect (see Appendix). The radiographic
osteoarthritis scoring was grade 0 (no evidence of osteoarthritis) in twelve (48%) of these hips, grade 1 (sclerosis only) in
nine (36%), and grade 2 (moderate joint space narrowing) in
four (16%). All samples from hips with end-stage osteoarthritis
were classified as showing a full-thickness defect, and the radiographic scoring was grade 3 (severe joint space narrowing)
in all of these hips. Analysis of gene expression according to
the intraoperative classification of articular cartilage damage
(Fig. 2) revealed that the expression of certain chemokine
(IL-8, CXCL2, CXCL3, and CCL3L1) and extracellular matrix
(ACAN) genes was significantly higher in the cleavage/thinning
stage.
Gene expression was generally lower in the control cartilage than in the other groups except in the case of IL-1b,
which was expressed at a relatively similar level in the control
cartilage and cartilage at the cleavage/thinning stage.
Discussion
emoroacetabular impingement is a common cause of hip
pain in adolescents and young adults31, and it has been
implicated as an important etiologic factor in secondary hip
osteoarthritis. In recent years, a better understanding of the
clinical presentation and structural characteristics of this
condition has led to increased utilization of surgical procedures designed to preserve the hip joint with the aim of relieving symptoms, enhancing function, and improving the
mechanical environment of the hip joint. Although an increasing body of literature suggests that femoroacetabular
impingement plays a role in the development of secondary
osteoarthritis3,4,31, there remains substantial controversy regarding
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this topic6,32. Additionally, the impact of femoroacetabular
impingement on articular cartilage and joint biology at the
cellular and molecular level is poorly understood. In order
to better understand the biological link between femoroacetabular impingement and osteoarthritis, we compared the
expression of cytokine, chemokine, degradative enzyme, and
cartilage matrix genes in articular cartilage from hips with
femoroacetabular impingement, normal hips, and hips with
osteoarthritis. Furthermore, we compared gene expression in
the articular cartilage from hips in various stages of the osteoarthritic cascade (as determined by intraoperative morphologic grading).
To our knowledge, this is the first report of metabolic
activity levels in the articular cartilage of human subjects with
femoroacetabular impingement. Articular cartilage obtained
from the impingement zone (anterolateral head-neck junction)
of hips with femoroacetabular impingement expressed markedly elevated levels of most chemokines and degradative enzymes, but not of the proinflammatory cytokine IL-1b, compared
with normal articular cartilage (Fig. 1). Cartilage specimens
from hips with femoroacetabular impingement also expressed
significantly higher levels of certain chemokines and other
markers (IL-8, CCL3L1, ADAMTS-4, and ACAN) compared
with articular cartilage from hips with end-stage osteoarthritis.
In the comparison among different stages of articular cartilage
degradation, the cleavage/thinning stage was the most metabolically active as indicated by our panel of target genes. Importantly, there was a trend toward decreased expression of
matrix protein genes (COL2A1 and ACAN) in end-stage osteoarthritis compared with femoroacetabular impingement,
although this decrease was significant only for ACAN.
The early pathophysiology of osteoarthritis is poorly
understood, and very limited information exists regarding the
biologic cascade that mediates osteoarthritis in the human hip.
Nevertheless, previous work suggests that early changes after
injury to articular cartilage include hypertrophy, collagen deformation, proteoglycan depletion, and mild inflammation33-35.
These events are reversible, as chondrocytes can degrade
damaged molecules and increase matrix production36. Thus,
both anabolism and catabolism are increased in early osteoarthritis, with the balance moving toward catabolism with
disease progression33. These previous observations are consistent with the data from the hips with femoroacetabular impingement and osteoarthritis in the present study (Fig. 1). The
samples from hips with femoroacetabular impingement demonstrated higher metabolic activity involving inflammatory
chemokine (IL-8 and CCL3L1), matrix-degrading (ADAMTS-4),
and extracellular matrix (ACAN) genes compared with hips
with end-stage osteoarthritis. The decrease in matrix protein
gene expression in hips with end-stage osteoarthritis may indicate a loss of anabolic activity and an imbalance favoring
catabolism.
Conventional diagnosis and treatment of pre-arthritic,
early arthritic, and advanced arthritic conditions is highly dependent on patient symptoms, physical examination, and radiographic evaluation 20. It is important to note that the
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majority (84%) of the hips with femoroacetabular impingement in the present study had no or only early radiographic
signs of osteoarthritis (Tönnis grade 0 or 1), yet the alterations
in articular cartilage metabolic activity were profound. This
finding underscores the concept that the biology of the osteoarthritic cascade far precedes radiographic evidence of disease.
Consequently, alternative methods of diagnosis and disease
staging are being investigated. Biologic markers from blood,
urine, and synovial fluid are considered potential candidates for
future diagnostic and disease staging strategies37,38. In the present
study, articular cartilage from hips with femoroacetabular impingement demonstrated a ‘‘molecular signature’’ compared
with normal cartilage. Several of the chemokines that were highly
expressed in cartilage from hips with femoroacetabular impingement were most markedly elevated when the stage of articular cartilage degeneration was classified as chondromalacia or
cleavage/thinning. These morphologic stages of articular cartilage degeneration commonly precede radiographic osteoarthritic
changes, suggesting that specific cytokine and chemokine gene
expression levels may have potential in characterizing the early
(pre-arthritic) molecular changes that are occurring in articular
cartilage. These new findings provide a basis for pursuing distinct
chemokines as candidate biomarkers for the diagnosis and
staging of pre-osteoarthritic and early osteoarthritic disorders39.
Another important aspect of this study was the availability of control hip cartilage samples from age-matched
subjects without osteoarthritis who were undergoing hip surgery. These samples provided baseline data for comparison
with tissue from hips with femoroacetabular impingement and
osteoarthritis. Nevertheless, the study has limitations. First,
although we identified local alterations in articular cartilage
gene expression in femoroacetabular impingement that may
mediate the osteoarthritic cascade, we have not identified the
specific molecular and/or mechanistic role of each factor in the
pathophysiology of femoroacetabular impingement, as such
studies were beyond the scope of this report. Future investigations will focus on the mechanisms of the osteoarthritic cascade. Second, we measured gene expression in only one specific
area of articular cartilage (the anterolateral femoral head-neck
junction); the expression and molecular characteristics of articular cartilage in other areas of the hip were not determined.
This limitation could not be overcome because the surgical goal
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of preserving the joint in patients with femoroacetabular impingement excluded the possibility of harvesting tissues from
other regions. Therefore, the impact of femoroacetabular impingement pathomechanics on articular cartilage away from
the impingement zone remains unclear.
In conclusion, these findings provide novel information regarding the pathophysiology of femoroacetabular
impingement and the molecular basis of human hip osteoarthritis. Specifically, we demonstrated the feasibility of
analyzing gene expression in articular cartilage samples obtained from the impingement zone at the time of joint
preservation surgery. Analysis of these tissues suggests that
the mechanical disease of femoroacetabular impingement
causes localized articular cartilage alterations that are consistent with early osteoarthritic degeneration. Specifically,
articular cartilage in the femoroacetabular impingement
zone had high metabolic activity, both catabolic and anabolic, that commonly preceded radiographic evidence of
osteoarthritis.
Appendix
A table showing the Beck criteria for intraoperative
grading of articular cartilage lesions is available with the
online version of this article as a data supplement at jbjs.org. n
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